Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-01-09 4 AS $94.14 $188,286 D/D (2,000) 225,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-02 4 AS $108.44 $542,195 D/D (5,000) 220,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-02 4 AS $107.96 $323,893 I/I (3,000) 43,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-03 4 AS $107.42 $537,097 D/D (5,000) 215,157 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-04 4 AS $107.71 $98,660 I/I (916) 42,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-16 4 AS $123.48 $123,477 I/I (1,000) 35,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-17 4 AS $124.87 $124,866 I/I (1,000) 34,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-20 4 AS $126.40 $126,396 I/I (1,000) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $422,590 D/D (3,506) 251,251 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $2,717,546 I/I (22,546) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $2,669,517 I/I (23,218) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $402,992 D/D (3,505) 248,654 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-08-12 4 AS $134.72 $202,083 I/I (1,500) 28,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-09-14 4 AS $131.43 $131,432 I/I (1,000) 27,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-10-15 4 AS $108.24 $108,241 I/I (1,000) 26,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-11-30 4 AS $94.74 $94,744 I/I (1,000) 25,758 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-03-01 4 AS $84.22 $842,769 D/D (10,000) 340,500 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-02 4 AS $85.01 $3,102,931 D/D (36,500) 395,635 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-05-05 4 AS $80.15 $4,007,445 I/I (50,000) 0 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-06-16 4 AS $80.55 $3,356,196 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-07-18 4 AS $92.72 $3,863,272 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-08-16 4 AS $91.49 $3,811,868 D/D (41,666) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-15 4 AS $94.85 $4,038,360 D/D (42,577) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-16 4 AS $95.25 $9,058,600 D/D (94,791) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 AS $93.65 $4,974,901 D/D (53,125) 378,584 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9  10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 9 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us